As a tumor promoter, MALAT-1 could be transcriptionally activated by c-Fos and could interact with Ezh2, silencing the tumor suppressor gene E-cadherin and upregulating β-catenin expression that induce tumor promotion in RCC [31]. The gene discussed is FOS; the disease is renal cell carcinoma.